Pfizer to cut 300 Canadian jobs
Pfizer Inc. is laying off 300 professionals or 11 per cent of its Canadian workforce as the drug multinational reduces its costs to soothe the revenue erosion from expired patents such as its blockbuster cholesterol-lowering drug Lipitor.
A majority of the job cuts will occur in sales and marketing, according to Rhonda O’Gallagher, executive director, corporate communications at Pfizer Canada Inc.
No comments:
Post a Comment